In a new publication, researchers from the German Center for Diabetes Research (DZD) and the University of Medicine ...
Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.
Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.
CANTANHEDE, PORTUGAL, NEW YORK CITY, USA AND DUBLIN, IRELAND, January 12, 2026 /EINPresswire.com/ -- • An early-phase ...
FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.
• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...
By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results